Targets Trust XXIV TARGETS 7%INTC (TOI)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 0.9511 |
| Open | 0.9700 |
| Bid | 0.8947 x 200 |
| Ask | 0.9351 x 200 |
| Day's range | 0.8801 - 0.9999 |
| 52-week range | 0.3300 - 2.6550 |
| Volume | |
| Avg. volume | 124,455 |
| Market cap | 69.111M |
| Beta (5Y monthly) | 0.83 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Insider Monkey
The Oncology Institute, Inc. (NASDAQ:TOI) Q4 2023 Earnings Call Transcript
The Oncology Institute, Inc. (NASDAQ:TOI) Q4 2023 Earnings Call Transcript March 27, 2024 The Oncology Institute, Inc. misses on earnings expectations. Reported EPS is $-0.21 EPS, expectations were $-0.11. TOI isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, […]
- Simply Wall St.
Oncology Institute Full Year 2023 Earnings: US$0.92 loss per share (vs US$0.001 profit in FY 2022)
Oncology Institute ( NASDAQ:TOI ) Full Year 2023 Results Key Financial Results Revenue: US$324.2m (up 28% from FY...
- GuruFocus.com
The Oncology Institute Inc (TOI) Reports Mixed Q4 and Full Year 2023 Results
TOI's Revenue Rises but Net Loss Deepens; Provides 2024 Financial Guidance
© 2024 Yahoo. All rights reserved.